老年肺腺癌病人术前全身免疫炎症指数/血清白蛋白与临床病理特征的相关性研究

doi:10.3969/j.issn.1003-9198.2024.09.008

摘要/Abstract

摘要： 目的探讨术前全身免疫炎症指数/血清白蛋白(SII/ALB)与老年肺腺癌病人临床病理特征的相关性。方法回顾性分析2020年1月至2023年6月于南京医科大学附属老年医院接受胸腔镜手术治疗的103例老年肺腺癌病人的临床病理资料,根据术前检验结果计算出SII/ALB值,以SII/ALB中位数将病人分为高SII/ALB组和低SII/ALB组,分析2组病人临床病理特征的差异。结果 103例老年肺腺癌病人的SII/ALB中位数为16.1,低SII/ALB组(SII/ALB≤16.1)47例,高SII/ALB组(SII/ALB＞16.1)56例。2组间BMI、高级别腺癌成分、胸膜侵犯、TNM分期、淋巴结转移、气道播散比例比较,差异均有统计学意义(P＜0.05);相关分析结果显示,SII/ALB水平与TNM分期、淋巴结转移相关(P＜0.05)。结论 SII/ALB反映了肿瘤病人的免疫、炎症以及营养三方面状态。SII/ALB水平与TNM分期、淋巴结转移相关,监测SII/ALB水平有助于为老年肺腺癌的临床诊疗提供一定的参考信息。

关键词: 肺肿瘤, 腺癌, 全身免疫炎症指数/血清白蛋白, 临床病理特征, 相关性, 老年人

Abstract: Objective To investigate the correlation between preoperative systemic immunoinflammatory index/serum albumin (SII/ALB) and clinicopathological features in the elderly patients with lung adenocarcinoma. Methods The clinicopathological data of 103 elderly patients with lung adenocarcinoma treated by thoracoscopic surgery in Geriatric Hospital of Nanjing Medical University from January 2020 to June 2023 were retrospectively analyzed. SII/ALB value was calculated according to preoperative test results, and the patients were divided into high SII/ALB group and low SII/ALB group according to the median SII/ALB value. The relationship between SII/ALB and clinicopathological features of the patients was analyzed. Results The median SII/ALB was 16.1, and there were 47 cases in low SII/ALB group (SII/ALB≤16.1) and 56 cases in high SII/ALB group (SII/ALB > 16.1). There were significant differences in BMI, high-grade adenocarcinoma components, pleural invasion, TNM stage, lymph node metastasis and airway spread between the two groups (P<0.05). The level ofSII/ALB was correlated with TNM stage and lymph node metastasis (P<0.05). Conclusions SII/ALB reflects the immune, inflammatory and nutritional status of the patients. SII/ALB level is related to TNM stage and lymph node metastasis. Monitoring SII/ALB level is helpful to provide certain reference information for the clinical diagnosis and treatment of elderly lung adenocarcinoma.

Key words: lung tumor, adenocarcinoma, systemic immunoinflammatory index/serum albumin, clinicopathological features, correlation, aged

中图分类号:

R734.2

李江, 邱雁, 王婷, 王丹, 虞一帆, 濮玲丽, 卜玲. 老年肺腺癌病人术前全身免疫炎症指数/血清白蛋白与临床病理特征的相关性研究[J]. 实用老年医学, 2024, 38(9): 893-896.

LI Jiang, QIU Yan, WANG Ting, WANG Dan, YU Yifan, PU Lingli, BU Ling. Correlation between preoperative SII/ALB and clinicopathologic features in elderly patients with lung adenocarcinoma[J]. Practical Geriatrics, 2024, 38(9): 893-896.

参考文献

[1] 方乐平,董振,樊卫飞.转录因子激活蛋白-2a在老年肺腺癌患者中的表达情况及与临床病理参数的相关性[J]. 实用老年医学,2021,35(10):1036-1039,1044.
[2] JOMRICH G, GRUBER E S, WINKLER D,et al.Systemic immune-inflammation index (SII) predicts poor survival in pancreatic cancer patients undergoing resection[J]. J Gastrointest Surg, 2020,24(3):610-618.
[3] 马丽娟,王蕴,李殿明.血清CEA、D-D、ALB、NLR与非小细胞肺癌的相关性及联合诊断价值分析[J]. 标记免疫分析与临床,2021,28(9):1537-1541,1548.
[4] 姜源.SII/ALB对小细胞肺癌患者的临床预后价值[D]. 青岛:青岛大学,2019.
[5] 张妍妍.老年非小细胞肺癌患者的临床病理特征及预后分析[D]. 西安:西安医学院,2020.
[6] 芦翼飞,任中海,王磊,等.补体C3和C4表达水平与早期非小细胞肺癌老年肥胖患者临床病理特征及预后的相关分析[J].实用癌症杂志, 2022,37(3):367-375.
[7] TIAN Y, MA L, ZHANG P, et al. Prognostic value of systemic immune-inflammation index/albumin for transcatheter arterial chemoembolization treatment[J]. Heliyon, 2023,9(4):e15156.
[8] LABELLE M,BEGUM S,HYNES R O. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis[J]. Cancer cell, 2011, 20(5):576-590.
[9] GIESE M A,HIND L E,HUTTENLOCHER A.Neutrophil plasticity in the tumor microenvironment[J]. Blood,2019,133(20):2159-2167.
[10] 张宇,汪亦民,薛英威.全身免疫炎症指数(SII)与胃癌患者临床病理因素及预后的相关性[J]. 现代肿瘤医学,2021,29(3):441-445.
[11] 杭航,贾哲,朱佳丽,等.全身免疫炎症指数在消化系统疾病中的研究进展[J]. 新医学,2022,54(6):400-403.
[12] XIONG S, DONG L, CHENG L.Neutrophils in cancer carcinogenesis and metastasis[J]. J Hematol Oncol, 2021,14(1):173.
[13] SCHUMACHER D, STRILIC B, SIVARAJ K, et al. Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor[J]. Cancer Cell,2013,24(1):130-137.
[14] GUPTA D,LIS C G.Pretreatment serum albumin as a predictor of cancer survival:a systematic review of the epidemiological literature[J]. Nutr J,2010,9:69.
[15] 宋建宁,李俊,杨鋆,等.全身免疫炎症评分与结直肠癌临床病理特征的相关性分析[J]. 中华消化外科杂志,2021,20(10):1081-1097.
[16] 孟园园.术前AFP联合SII/ALB检测对早期肝细胞癌射频消融术预后的临床意义[D]. 郑州:郑州大学,2022.
[17] 李红伟,张保华,郑瑶,等.胸腺素β4表达与术前SII/ALB水平对早期可手术NSCLC患者预后的预测价值[J]. 中国医师杂志,2022,24(12):1847-1851,1856.
[18] CERASUOLO A,ANNUNZIATA C,TORTORA M,et al.Comparative analysis of HPV16 gene expression profiles in cervical and in oropharyngeal squamous cell carcinoma[J]. Oncotarget, 2017,8(21):34070-34081.
[19] 刘俊伦,哈敏文.第7版、第8版肺癌TNM分期对NSCLC患者预后判断的差异[J]. 医学与哲学,2018,39(8):45-48.
[20] 吴江华,孙蕾娜,林冬梅.肺癌气腔播散病理研究进展[J]. 中华病理学杂志,2023,52(2):184-188.
[21] SIERKO E, WOJTUKIEWICZ M Z.Platelets and angiogenesis in malignancy.[J]. Semin Thromb Hemost,2004,30(1):95-108.
[22] FENG J F, HUANG Y, CHEN Q X. Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma[J]. World J Surg Oncol,2014,12:58.
[23] TAVARES S M, JUNIOR WDE L, LOPES E SILVA M R.Normal lymphocyte immunophenotype in an elderly population[J]. Rev Bras Hematol Hemoter,2014,6(3):180-183.
[24] 李婵,吴远鹏,吴吉进,等.SII预测恶性实体肿瘤预后的研究进展[J]. 实用医院临床杂志,2018,15(3):252-254.